Streptozotocin: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
{{Short description|A chemical compound used in medical research and treatment of certain cancers}} | |||
{{Drugbox | |||
| verifiedfields = changed | |||
| verifiedrevid = 477002123 | |||
| IUPAC_name = N-((4-Oxo-1,2,3,4-tetrahydro-2H-1,3,2-oxazaphosphinin-2-yl)methyl)urea | |||
| image = Streptozocin_(Haworth).svg | |||
| image_size = 250px | |||
| image_alt = Structural formula of Streptozotocin | |||
}} | |||
'''Streptozotocin''' (also known as '''streptozocin''') is a naturally occurring chemical that is particularly toxic to the insulin-producing beta cells of the pancreas in mammals. It is used in medical research to induce diabetes in experimental animals and is also used in the treatment of certain types of cancer, particularly [[pancreatic cancer]]. | |||
==Chemical Structure and Properties== | |||
[[File:Streptozocin_(Haworth).svg|thumb|right|Structural formula of Streptozotocin]] | |||
Streptozotocin is a [[nitrosourea]] compound, which is a class of compounds known for their ability to alkylate DNA. Its chemical structure includes a glucose moiety, which facilitates its uptake by the beta cells of the pancreas. This selective uptake is due to the presence of the glucose transporter GLUT2 on the surface of these cells. | |||
== | ==Mechanism of Action== | ||
Streptozotocin exerts its effects primarily through the alkylation of DNA, leading to DNA damage and cell death. In pancreatic beta cells, this results in the destruction of insulin-producing cells, thereby inducing a state of [[diabetes mellitus]] in experimental models. This property is exploited in research to study the pathophysiology of diabetes and to test potential therapeutic interventions. | |||
==Medical Uses== | |||
Streptozotocin is used clinically in the treatment of [[metastatic]] [[pancreatic islet cell carcinoma]], a type of [[neuroendocrine tumor]]. Its ability to selectively target pancreatic cells makes it useful in this context. The drug is administered intravenously and is often used in combination with other chemotherapeutic agents to enhance its efficacy. | |||
== | ==Side Effects== | ||
The use of streptozotocin can lead to several side effects, primarily due to its cytotoxic nature. Common side effects include [[nausea]], [[vomiting]], and [[nephrotoxicity]]. The latter is a significant concern, as streptozotocin can cause damage to the kidneys, necessitating careful monitoring of renal function during treatment. | |||
==Research Applications== | |||
In addition to its clinical applications, streptozotocin is widely used in research to create animal models of diabetes. By selectively destroying pancreatic beta cells, researchers can study the effects of insulin deficiency and test new treatments for diabetes. This has been instrumental in advancing our understanding of the disease and developing new therapeutic strategies. | |||
== | ==Related pages== | ||
* [[Diabetes mellitus]] | |||
* [[Pancreatic cancer]] | |||
* [[Neuroendocrine tumor]] | |||
* [[Chemotherapy]] | |||
[[Category:Chemotherapy agents]] | |||
[[Category:Diabetes research]] | |||
[[Category:Nitrosoureas]] | |||
[[Category: | |||
[[Category: | |||
[[Category: | |||
Latest revision as of 11:22, 15 February 2025
A chemical compound used in medical research and treatment of certain cancers
Streptozotocin (also known as streptozocin) is a naturally occurring chemical that is particularly toxic to the insulin-producing beta cells of the pancreas in mammals. It is used in medical research to induce diabetes in experimental animals and is also used in the treatment of certain types of cancer, particularly pancreatic cancer.
Chemical Structure and Properties[edit]
Streptozotocin is a nitrosourea compound, which is a class of compounds known for their ability to alkylate DNA. Its chemical structure includes a glucose moiety, which facilitates its uptake by the beta cells of the pancreas. This selective uptake is due to the presence of the glucose transporter GLUT2 on the surface of these cells.
Mechanism of Action[edit]
Streptozotocin exerts its effects primarily through the alkylation of DNA, leading to DNA damage and cell death. In pancreatic beta cells, this results in the destruction of insulin-producing cells, thereby inducing a state of diabetes mellitus in experimental models. This property is exploited in research to study the pathophysiology of diabetes and to test potential therapeutic interventions.
Medical Uses[edit]
Streptozotocin is used clinically in the treatment of metastatic pancreatic islet cell carcinoma, a type of neuroendocrine tumor. Its ability to selectively target pancreatic cells makes it useful in this context. The drug is administered intravenously and is often used in combination with other chemotherapeutic agents to enhance its efficacy.
Side Effects[edit]
The use of streptozotocin can lead to several side effects, primarily due to its cytotoxic nature. Common side effects include nausea, vomiting, and nephrotoxicity. The latter is a significant concern, as streptozotocin can cause damage to the kidneys, necessitating careful monitoring of renal function during treatment.
Research Applications[edit]
In addition to its clinical applications, streptozotocin is widely used in research to create animal models of diabetes. By selectively destroying pancreatic beta cells, researchers can study the effects of insulin deficiency and test new treatments for diabetes. This has been instrumental in advancing our understanding of the disease and developing new therapeutic strategies.
.svg){kind=link}